← All organizations
Highest phase reached
Phase 4
Acquired by Jaguar Health on Jan 1, 2017
Timeline
2000s
- Jan 1, 2001
Napo Pharmaceuticals— Founded
2010s
- Dec 31, 2012
crofelemer— NDA Secondary Org
- Jan 1, 2017
Jaguar Health— Acquired By
Drugs by trial phase (15 distinct, 13 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (15)
- NCT06904872Lead sponsorPhase 2May 29, 2025
- NCT06721871Lead sponsorPhase 2Jan 31, 2025
- NCT06721871OfficialPhase 2Jan 31, 2025
- NCT06326645CollaboratorEarly Phase 1Dec 1, 2024
- NCT04538625Study chairPhase 3Oct 7, 2020
- NCT04538625Lead sponsorPhase 3Oct 7, 2020
- NCT04192487Lead sponsorPhase 4Oct 22, 2019
- NCT03898856CollaboratorPhase 4Apr 1, 2019
- NCT02910219CollaboratorPhase 2Jan 31, 2017
- NCT03094052CollaboratorPhase 2Jan 4, 2017
- NCT02388373CollaboratorPhase 4Jul 1, 2014
- NCT01678430CollaboratorPhase 3Dec 1, 2011
- NCT00784810Lead sponsorPhase 4Feb 1, 2009
- NCT00324038Lead sponsorPhase 4Mar 1, 2006
- NCT00312195CollaboratorPhase 3Mar 1, 2001
Details
- Founded
- San Francisco, CA, US Jan 1, 2001
- Last known activity
- May 29, 2025
Notes
Acquired by Jaguar Health